We are live on ! Find out more
BSTG

Biostage, Inc. Common Stock
BSTG

Delisted

BSTG was delisted on the 5th of October, 2017.

51 hedge funds and large institutions have $31.1M invested in Biostage, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more capital invested

Capital invested by funds: $16.7M → $31.1M (+$14.4M)

8% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 13

4% less funds holding

Funds holding: 5351 (-2)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

Holders
51
Holders Change
-2
Holders Change %
-3.77%
% of All Funds
1.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
14
Reduced
13
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MOACM
51
Mutual of America Capital Management
New York
-$309K -65,051 Closed
JG
52
Jefferies Group
New York
-$238K -50,000 Closed
CSM
53
Central Square Management
Illinois
-$177K -37,267 Closed
VDBMI
54
Van Den Berg Management I
Texas
-$140K -29,565 Closed
Acadian Asset Management
55
Acadian Asset Management
Massachusetts
-$106K -22,369 Closed
YCM
56
Yakira Capital Management
Connecticut
-$70K -14,777 Closed
Royal Bank of Canada
57
Royal Bank of Canada
Ontario, Canada
-$7K -1,500 Closed
Bank of America
58
Bank of America
North Carolina
-$1.26K -212 -99%
Ameriprise
59
Ameriprise
Minnesota
+$59 +10 New

BSTG Hedge Fund Activity: Q1 2014 in Review

51 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q1 2014, worth a combined $31.1M — up 86% from $16.7M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of BSTG and 7 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 14 added.

The largest buyer was Penbrook Management, adding an estimated $825K. The largest seller was BlackRock Institutional Trust, cutting an estimated $473K.

  • 51 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q1 2014, down from 53 in Q4 2013.
  • Funds reported $31.1M of Biostage, Inc. Common Stock stock for Q1 2014, up 86% quarter-over-quarter.
  • 7 funds opened new Biostage, Inc. Common Stock positions in Q1 2014 and 9 closed out, a net change of -2 holders.
  • The largest Biostage, Inc. Common Stock buyer in Q1 2014 was Penbrook Management, an estimated $825K added.
  • The largest Biostage, Inc. Common Stock seller in Q1 2014 was BlackRock Institutional Trust, an estimated $473K sold.

Based on aggregated 13F filings for Q1 2014.